Risk assessment in patients with stable coronary artery disease: Incremental value of nuclear imaging
Article
- 27 Downloads
- 13 Citations
Conclusion
Risk stratification with nuclear testing is likely to find applicability in an increasing number of subsets of patients with CAD. This discussion focuses on data derived predominantly from patients with varying like-lihoods of CAD. In virtually all groups of patients with CAD there are subsets who have intermediate risk for subsequent cardiac events who can be risk-stratified effectively with nuclear techniques, including patients with medically stabilized unstable angina, those who have had MI, those who have undergone revascularization, those preparing for operation, and those with heart failure.
Keywords
Event Rate Nuclear Cardiology Berman Nuclear Testing Hard Event
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
- 1.Brown KA, Boucher CA, Okada RD, et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983;1:994–1001.PubMedCrossRefGoogle Scholar
- 2.Staniloff HM, Forrester JS, Berman DS, Swan HJC. Prediction of death, myocardial infarction, and worsening chest pain using thallium scintigraphy and exercise electrocardiography. J Nucl Med 1986;27:1842–8.PubMedGoogle Scholar
- 3.Ladenheim ML, Kotler TS, Pollock BH, Berman DS, Diamond GA. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Am J Cardiol 1987;59:270–7.PubMedCrossRefGoogle Scholar
- 4.Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22: 665–70.PubMedGoogle Scholar
- 5.Berman DS, Kiat H, Friedman JD, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455–64.PubMedGoogle Scholar
- 6.Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905–14.PubMedGoogle Scholar
- 7.Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639–47.PubMedCrossRefGoogle Scholar
- 8.Hachamovitch R, Kiat H, Amanulia A, et al. Nuclear testing in patients with a high pre-scan likelihood of CAD or previous MI: is there benefit from added prognostic value? J Am Coll Cardiol 1996;27:1084.Google Scholar
- 9.Hachamovitch R, Berman DS, Kiat H, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996;28:34–44.PubMedCrossRefGoogle Scholar
- 10.Berman D, Hosen K, Hachamovitch R, et al. Prediction of cardiac mortality in 5125 patients using stress technetium-99m myocardial perfusion SPECT [abstract]. J Am Coll Cardiol 1996;27(Suppl A):285A.CrossRefGoogle Scholar
- 11.Hachamovitch R, Berman D, Kiat H, Cohen I, Cabico A, Diamond G. What is the warranty for normal exercise sestamibi SPECT? Circulation 1995;92:1–52.Google Scholar
Copyright information
© American Society of Nuclear Cardiology 1996